12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Cohort Profile: The PERU MIGRANT Study–A prospective cohort study of rural dwellers, urban dwellers and rural-to-urban migrants in Peru

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Why was the cohort set up? Infectious diseases are still a major concern in developing countries, causing up to 60% of the deaths in low-income countries. However, non-communicable diseases (NCDs) and their associated risk factors are becoming a major public health issue in the developing world where between 38% (low-income) and 80% (upper middle-income) of deaths are attributable to NCDs. 1 , 2 Major common risk factors include raised blood pressure, elevated blood glucose, obesity, low physical activity, unhealthy diet habits, smoking and alcohol consumption. Many risks are associated with lifestyle and have rapidly changed over recent decades, some driven by urbanization. 3 , 4 Environmental changes as well as population flow have led to an increase in urbanization. The degree of urbanization is closely linked to distinctive features of the health profile of rural and urban participants, as well as of rural-to-urban migrants. Internal migration led to an ‘urbanization’ of the individuals who were born in rural settings and causes a change in their lifestyle habits. Low physical activity, for example, is linked to urban settings whereas agriculture, the main labour in the rural area, implies high physical activity. Within-country migration is a complex phenomenon and can be driven by many reasons, including but not limited to the aspiration to seek better socioeconomic standards or living conditions, war displacement and natural disasters. The PERU MIGRANT Study (PEru's Rural to Urban MIGRANTs Study) was conducted to identify the impact of rural-to-urban migration on selected cardiometabolic outcomes, e.g. obesity, type-2 diabetes and hypertension. The study includes rural-to-urban migrants as well as rural and urban non-migrant groups. 5 Because of political violence between the 1970s and 1990s, approximately 120 000 families moved from rural highlands to urban coastal settlements in Peru. 6 , 7 This scenario offered an opportunity to study rural-to-urban migration without the potential bias introduced by socioeconomic improvement, thus decreasing the impact of selection bias. The research questions addressed by the PERU MIGRANT Study were: Is there a difference in specific cardiovascular disease (CVD) risk factors in rural-to-urban migrants compared with those rural or urban dwellers who did not migrate? Do CVD risk factor patterns among migrant populations vary by: length of residence in urban environment? lifetime exposure to urban environment? age at first migration? We considered analysing the exposure to the urban environment as years and percentage of life exposure. Thus, the length of urban residence was considered as the number of years that the rural-to-urban migrants reported to had lived in an urban setting. On the other hand, lifetime exposure was the percentage obtained by dividing the number of years lived in an urban area by participant’s current age in years. Settings The PERU MIGRANT Study was conducted in Lima, an urban sea-level setting, and Ayacucho, a rural high-altitude setting located at 2761 m above sea level. The reason for choosing these sites was for convenience. The research team had conducted other studies previously in these settings, or were close to researchers who had worked there previously. Ayacucho is an Andean department considered one of the areas most affected by political violence that occurred between 1970 and 1980. About 50% of all deaths caused by terrorism occurred in this area. 7 Approximately 11% of the total migrants to Lima were from Ayacucho. 8 These figures made Ayacucho the leading source of rural-to-urban migrants to Lima. We selected the village of San Jose de Secce, in the district of Santillana, province of Huanta, in Ayacucho as the rural study site. In San Jose, 50% of the population is considered extremely poor, with only 5% of residents having direct access to potable water. In addition, the literacy rate is around 60% and the main language is Quechua. 9 The peri-urban shanty town called Las Pampas de San Juan de Miraflores, in the south of Lima, was chosen as the urban study site. The definition we consider for ‘urban’ is having approximately 100 houses clustered. The population in this area is ‘extremely poor’ and up to 20% is ‘poor’. Literacy rate is 79% and the main language is Spanish. Both sites represent the urban, migrant and rural populations due to the number of participants and environmental characteristics. Funding for the baseline assessment was provided by the Wellcome Trust. The first follow-up assessment was partly funded by the Universidad Peruana Cayetano Heredia. The second follow-up round was partly funded by the GloCal Health Fellowship Program from the University of California Global Health Institute. Who is in the cohort? In 2007, adult subjects from San Jose de Secce rural group were identified after a census was made. The 2006 updated Las Pampas de San Juana de Miraflores census was used to identify urban residents who were born in Lima (urban dwellers) and who were born in Ayacucho (rural-to-urban migrants). Participants were recruited using a single-stage random sampling technique that was sex- and age-stratified (30–39, 40–49, 50–59 and ≥60 years) using name, address and national identification number. Men and women ≥ 30 years old and permanent residents were considered eligible for the study. Pregnant women and those with mental conditions that would have prevented completion of the study procedures were excluded. Power calculations were derived using conservative estimates of the prevalence of major risk factors in the areas of Huaraz (urban, Andes) and Ingenieria (urban, Lima). The baseline survey, conducted in 2007–08, was designed to include 1000 participants: 200 born in Ayacucho who have always lived in rural areas, 600 rural-to-urban migrants born in Ayacucho and living in Pampas de San Juan de Miraflores in Lima and 200 urban participants who have always lived in urban areas. Comparing the Lima with the Andes group, at least 200 people in each group would give a power of 80% and a significance level of 5% to detect a difference in the prevalence of hypertension (33% vs 19.5%), hypercholesterolaemia (22.7% vs 10.6%) and diabetes (7.6% vs 1.3%). More rural-to-urban individuals were included to have further information from this group, because additionally, this group was expected to be divided into two groups to be analysed according to migration surrogates. A total of 1606 dwellers were invited to participate in the study. The general response rate at enrolment was 73.2% (1176/1606) and the overall response rate at completion was 61.6% (989/1606). Response rate was the highest in the rural group (84.8%), and the corresponding figures were 56.8% and 77.7% for urban and migrant groups, respectively. Further details about sample size and sample enrolment at baseline are available elsewhere. 5 Characteristics of the individuals who refused to participate in the baseline assessment, and reasons for refusal, have been previously published, 5 including having access to health care and thus not needing the health evaluation provided by the study, and logistical issues e.g. time constraints due to work or travel. 5 Before participation, an informed consent was signed by the participant. The protocol of the study was approved by the institutional review board of the Universidad Peruana Cayetano Heredia. How often have they been followed up? Five years after the baseline assessment, in 2012–13, the participants of the PERU MIGRANT Study were re-contacted for the first follow-up. A second follow-up assessment was completed in June 2016. The response rates for the first and second follow-up rounds were 93.8% and 85.6%, respectively (Figure 1 ). Figure 1 Number of participants in each round of the PERU MIGRANT Study. The percentages for follow-up rates do not include deaths in each group. The first follow-up evaluation aimed to revisit all 989 participants recruited at baseline. In this round, 33 deaths were recorded and 61 participants were lost to follow-up (Figure 1). Sociodemographic characteristics of participants re-contacted or lost to follow-up at the first follow-up round are presented in Table 1 and Table 2. Table 1 Characteristics of PERU MIGRANT Study participants at first follow-up round: deaths, lost-to-follow up and re-contacted Re-contacted participants Lost-to- follow-up participants Dead N = 33 Alive N = 895 Overall N = 61 Migration status     Rural 10 (30.3) 191 (21.3) 0 (0.0)     Migrant 14 (42.4) 526 (58.8) 49 (80.1)     Urban 9 (27.3) 178 (19.9) 12 (19.9) Age (years)     30–39 3 (9.1) 259 (28.9) 20 (32.8)     40–49 1 (3.0) 263 (29.4) 18 (29.6)     50–59 7 (21.2) 252 (28.2) 13 (21.4)     60+ 22 (66.7) 121 (13.5) 10 (16.4) Sex     Male 22 (66.7) 413 (46.1) 32 (52.5)     Female 11 (33.3) 482 (53.9) 29 (47.5) Education     Primary or less 24 (72.7) 430 (48.4) 26 (42.6)     Some secondary or more 9 (27.3) 463 (51.6) 35 (57.4) Asset index     Lowest 19 (57.8) 313 (35.0) 15 (24.6)     Middle 8 (24.2) 294 (32.9) 25 (40.9)     Highest 6 (18.1) 288 (32.2) 21 (34.4) The entries in parentheses refer to the corresponding percentages (%). Table 2 Characteristics of PERU MIGRANT Study participants at first follow-up round, i.e. deaths, lost-to-follow-up and re-contacted according to study group Re-contacted participants Lost-to-follow-up participants Rural N = 201 Migrant N = 540 Urban N = 185 Overall N = 61 Mortality 10 (5.0) 14 (2.6) 9 (4.8) – Age (years)     30–39 20 (9.9) 64 (11.9) 23 (12.4) 60 (98.4)     40–49 59 (29.4) 157 (29.4) 48 (25.9) 1 (1.6)     50–59 43 (21.4) 158 (29.3) 57 (30.8) –     60+ 55 (27.4) 135 (25.0) 47 (25.4) – Sex     Male 95 (47.3) 252 (46.7) 88 (47.1) 32 (52.5)     Female 106 (52.7) 288 (53.3) 99 (52.9) 29 (47.5) Education     None/some 132 (65.6) 168 (31.2) 13 (6.9) 15 (24.6)     Primary complete 30 (14.9) 92 (17.1) 19 (10.2) 11 (18.0)     Some secondary or more 39 (19.4) 279 (51.7) 154 (82.8) 35 (57.4) Asset index     Lowest 196 (97.5) 108 (20.0) 28 (14.9) 15 (24.6)     Middle 5 (2.5) 233 (43.2) 64 (34.2) 25 (40.9)     Highest 0 (0.0) 199 (36.9) 95 (50.8) 21 (34.4) The entries in parentheses refer to the corresponding percentages (%). Updated figures for 2016, after the second follow-up visit, include 57 deaths recorded and 142 participants lost to follow-up. Accordingly, to date, information from 847 participants, divided into 154 rural dwellers, 520 rural-to-urban migrants and 173 urban individuals, is available. The cumulative mortality after the second follow-up was 6.7% using 989 as the population’s denominator. Characteristics of re-contacted participants at the second follow-up round are presented in Table 3. Table 3 Characteristics of PERU MIGRANT study participants at second follow-up Re-contacted participants Rural N = 154 Migrant N = 520 Urban N = 173 Mortality 13 (8.4) 30 (5.8) 14 (8.1) Age (years)     30–39 – – –     40–49 41 (29.5) 147 (30.3) 43 (26.7)     50–59 37 (30.3) 153 (31.5) 53 (32.9)     60+ 61 (26.7) 186 (38.7) 65 (40.4) Sex     Male 63 (40.9) 241 (46.4) 77 (44.5)     Female 91 (59.1) 279 (53.7) 96 (55.5) Education     None/some 101 (65.6) 164 (31.6) 12 (7.0)     Primary complete 22 (14.3) 90 (17.3) 18 (10.4)     Some secondary or more 31 (20.1) 265 (51.1) 142 (82.6) Asset index     Lowest 149 (96.8) 103 (19.8) 29 (16.8)     Middle 5 (3.5) 222 (42.7) 60 (34.7)     Highest 0 (0.0) 195 (34.7) 95 (48.6) The entries in parentheses refer to the corresponding percentages (%). What has been measured? The baseline assessment of the PERU MIGRANT Study aimed to identify prevalence of CVD risk factors and major NCDs. These included: obesity, defined as BMI ≥ 30; hypertension, considered as the mean of three blood pressure measurements ≥ 140/90, or previous physician diagnosis or currently receiving treatment for hypertension; type 2 diabetes mellitus, considered in those with fasting glucose ≥ 126 mg/dl, or previous physician diagnosis or currently receiving treatment for diabetes. Dyslipidaemia was considered as total cholesterol ≥ 200 mg/dl, triglycerides ≥ 200 mg/dl, low-density lipoprotein (LDL) ≥ 160 mg/dl and high-density lipoprotein (HDL) ≤ 40 mg/dl for men and ≤ 50 mg/dl for women. Cardiovascular diseases (myocar-dial infarction and stroke) were considered as the self-report of previous diagnosis by a physician. Other risk factors assessed were: physical activity and tobacco and alcohol consumption. The follow-up rounds were conducted to study the incidence and risk of those NCDs and their associated risk factors. In addition, in order to better determine CVD, the second follow-up included an electrocardiographic evaluation in which signs of necrosis were considered for diagnosis. Variables collected throughout study rounds are summarized in Table 4. In brief, information was collected using: face-to-face questionnaires including sociodemographic variables, lifestyle behaviuors and self-reported clinical conditions; the clinical evaluation, e.g. anthropometric procedures and electrocardiogram; and blood samples, e.g. lipid profile, fasting glucose and inflammatory markers, among others. Table 4 Information collected at each study round, the PERU MIGRANT Study Phase Information collected Baseline 2007–08 Laboratory Fasting glucose, fasting insulin, glycosylated haemoglobin, lipid profile (total cholesterol, HDL-c, triglycerides), high ultrasensitive C-reactive protein, self-reported socioeconomic position Clinical examination Anthropometric measurements: weight, waist and hip circumferences, skinfolds (subcapsular, biceps, triceps and supra-iliac), blood pressures Questionnaire Self-reported NCDs (myocardial infarction, stroke, type 2 diabetes mellitus, dyslipidaemia), alcohol consumption, smoking status, mental health (12-item general health questionnaire), medication (specially antihypertensive and hypoglycaemic agents), socioeconomic factors, physical activity level (IPAQ), a social capital instrument validated in Peru, acculturation scale, Rose angina questionnaire First follow-up 2012–13 Clinical examination Anthropometric measurements: weight, height, waist and hip circumferences, blood pressures Questionnaire Self-reported NCDs, alcohol consumption, smoking status, mental health (12-item general health questionnaire), medication (specially antihypertensive and hypoglycaemic agents), verbal autopsy and death certificates if available Second follow-up 2015–16 Laboratory Fasting glucose Clinical examination Weight, body composition (bioimpedance) and blood pressure measurements, assessment using electrocardiogram (ECG) Questionnaire Questions related to the occurrence of cardiovascular diseases and/or risk factors such as previous diagnosis of myocardial infarction, hypertension, stroke, diabetes, physical activity level (IPAQ); plus self-rated status of health, medication and the patient health questionnaire (PHQ-9; mental health status) Personal histories of cardiovascular diseases and other non-communicable diseases were self-reported. What has it found? Key findings and publications Major findings from the baseline assessment identified a clear pattern of differences in cardiovascular risk factors according to migration status. 10 The length of urban residence had a robust impact on the prevalence of obesity in rural-to-urban migrants: 12% higher obesity prevalence was observed for each additional 10-year period of urban residence [95% confidence interval (CI) 6‐18]. 11 At baseline, prevalences of overweight, obesity and low physical activity were higher in the urban and migrant groups, relative to the rural group (P for trend = 0.001). 12 , 13 Predictably, urban participants were almost 33 times more likely to have low physical activity [odds ratio (OR) 32.98; 95% CI 11.02‐98.63]. Hypertension prevalence was higher in the urban (29%) and migrant (16%) groups; however; the difference in prevalence between the migrant and rural groups (11%) was not significant. 10 On the other hand, the overall prevalence of diabetes was 4.5% with a significant difference between groups (0.8%, 2.8% and 6.3% for rural, migrant and urban groups, respectively, P < 0.01). 14 Higher odds of impaired fasting glucose, metabolic syndrome and diabetes were found in participants who migrated at age ≥ 12 years vs their peers who migrated at younger ages. 14 A suboptimal control rate of hypertension was found in 95% of the hypertensive participants and 100% of those with diabetes, considering controlled those with blood pressure and HbA1c normal levels. For either or both conditions, treatment rates were higher in the urban than the migrant and rural groups, with a total of only 40% currently on medication. 14 Data from the first follow-up round addressed four main issues: all-cause and specific-cause mortality; 15 hypertension incidence; 16 obesity incidence; 17 and low HDL-cholesterol as a cardiovascular risk factor. 18 In both follow-up rounds, mortality data were collected through verbal autopsy and death certificates when available. In addition, in the second follow-up, since we could not re-contact all the participants from the baseline, we requested information from the national death records. Of the 33 deaths recorded in the first follow-up evaluation, nine were due to CVDs and eight due to cancer of unknown aetiology. Other causes included sepsis, accidental injuries and asthma, among others. In six cases, cause of death was undetermined. Men, older participants and individuals with hypertension, as well as those with lower education levels or a low assets index, were more likely to have died. There was a trend towards lower CVD mortality in migrant and rural dwellers, relative to urban counterparts. As such, urban dwellers were at higher risk of all-cause mortality compared with rural dwellers. 15 Regarding hypertension, the rural group showed greater risk of developing hypertension, when compared with their urban counterparts, and central obesity explained most of the new hypertension cases observed across study groups. 16 Relative to rural dwellers, the urban and migrant groups showed greater incidence of obesity. Migrant and urban participants showed an 8- and 9.5-fold higher incidence ratio of obesity compared with the rural group, respectively. Central obesity was the highest in the migrant group and its incidence ratio was associated with a higher assets index. 17 Finally, individuals with non-isolated low HDL-cholesterol had a 2- to 3-fold higher risk of CVD, including fatal stroke and myocardial infarction, at the first follow-up assessment. Furthermore, lower levels of HDL-cholesterol were found in the rural group compared with their migrant and urban counterparts. 18 What are the main strengths and weaknesses? The PERU MIGRANT Study followed three well-defined population groups: rural dwellers, rural-to-urban migrants and urban participants. The strength of the PERU MIGRANT Study does rely in its well-defined population groups: rural, urban and rural-to-urban migrants. A frequent and potential limitation of migration studies rests in the self-selection of the migrant participants due to better socioeconomic standards. Therefore, a strength of this cohort is that the migrants moved to urban settings due to political violence events, reducing the risk of socioeconomic selection bias. Finally, we re-contacted most of the initial study sample, particularly those in rural settings. Having completed two extensive follow-ups over an 8-year period, this cohort of rural-to-urban migrants and non-migrants is an asset for studies arising from low-income settings. Still, the PERU MIGRANT Study has several limitations. First, the sample size is rather small and statistical power for some analyses is restricted. Second, most of the refusals at baseline were observed in the oldest old and in male participants; however, the final cohort studied included similar proportions of sex and age, minimizing the selection bias. Furthermore, urban individuals who rejected participation in the study had higher education levels, compared with those enrolled in that group. This fact could be associated with a low socioeconomic status and less access to health care adding selection bias. 5 Finally, neither at baseline nor at the first follow-up round did we collect information about dietary patterns. Nevertheless, at the second follow-up a questionnaire to assess fat intake (e.g. low or high) was included. 19 This caveat could be overcome with the use of assumptions in interpreting results. For example, relative to rural participants, their urban fellows would consume more fat/energy-dense foods, and so would migrants. 20 In the future, further funding would enable a full assessment of markers in blood samples to complement the panel obtained at baseline, as well as measurements of fasting glucose obtained during the second follow-up, allowing for more comprehensive time variation analysis of glucose, lipid profiles, HbA1C and inflammatory markers. Can I get hold of the data? Where can I find out more? Baseline data can be freely accessed online at [https://figshare.com/articles/PERU_MIGRANT_Study_Baseline_dataset/3125005]. If interested in establishing collaborations, conducting analyses or having further information regarding the PERU MIGRANT Study, please send an e-mail to our research centre at [cronicas@oficinas-upch.pe]. Should you wish to use our data, please contact us with a brief analysis plan: title, research question, general or specific objectives, main variables and statistical analysis plan. Further information about our research group can be found at [http://en.cronicas-upch.pe/]. Funding The establishment of the PERU MIGRANT Study was funded through a Wellcome Trust Master Research Training Fellowship and a Wellcome Trust PhD Studentship to J.J.M. (074833/Z/04/A). The first follow-up evaluation was funded by Universidad Peruana Cayetano Heredia (Fondo Concursable No. 20205071009). The second follow-up evaluation was funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, through the GloCal Health Fellowship Program from the University of California Global Health Institute. R.M.C-L., A.B-O., J.J.M. and the CRONICAS Centre of Excellence in Chronic Diseases were supported by Federal Funds from the United States National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, under contract No. HHSN268200900033C. L.S. is a Wellcome Trust Senior Clinical Fellow (098504/Z/12/Z), and A.B-O. is a Wellcome Trust Research Training Fellow in Public Health and Tropical Medicine (103994/Z/14/Z). Conflict of interest: The authors declare no conflict of interest. PERU MIGRANT Study profile in a nutshell The cohort was established to study cardiovascular diseases and associated risk factors in three population groups in Peru: rural, urban and rural-to-urban migrants. The PERU MIGRANT Study’s posed hypothesis was that the occurrence and progression of cardiovascular disease and their risk factors would be different among these groups. Peru offers an unusual scenario to study rural-to-urban migration: a lot of migration happened in response to violence rather than economic issues, with a reduced likelihood of selection effects. The study was conducted in Ayacucho, a rural site, 2761 m above sea level, and in Lima, an urban site at sea level. The baseline assessment was in 2007–08, with 989 participants aged ≥ 30 years. There have been two follow-up evaluations conducted in 2012–13 and 2015–16. Out of the 989 people enrolled at baseline, 57 deaths were recorded and 142 participants were lost to follow-up, considering both study rounds. Although the second follow-up has been completed, the PERU MIGRANT is an ongoing cohort. We expect to re-contact the participants in the near future. Information collected throughout baseline, first and second follow-up rounds includes participants’ sociodemographic, behavioural and medical history and clinical data. Blood samples were taken at baseline and at the second follow-up evaluation only. Baseline data are available online at [https://figshare.com/articles/PERU_MIGRANT_Study_Baseline_dataset/3125005]. Collaboration proposals or requests for further information should be e-mailed to [cronicas@oficinas-upch-pe].

          Related collections

          Most cited references11

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Dietary Intake and Rural-Urban Migration in India: A Cross-Sectional Study

          Background Migration from rural areas of India contributes to urbanisation and lifestyle change, and dietary changes may increase the risk of obesity and chronic diseases. We tested the hypothesis that rural-to-urban migrants have different macronutrient and food group intake to rural non-migrants, and that migrants have a diet more similar to urban non-migrants. Methods and findings The diets of migrants of rural origin, their rural dwelling sibs, and those of urban origin together with their urban dwelling sibs were assessed by an interviewer-administered semi-quantitative food frequency questionnaire. A total of 6,509 participants were included. Median energy intake in the rural, migrant and urban groups was 2731, 3078, and 3224 kcal respectively for men, and 2153, 2504, and 2644 kcal for women (p<0.001). A similar trend was seen for overall intake of fat, protein and carbohydrates (p<0.001), though differences in the proportion of energy from these nutrients were <2%. Migrant and urban participants reported up to 80% higher fruit and vegetable intake than rural participants (p<0.001), and up to 35% higher sugar intake (p<0.001). Meat and dairy intake were higher in migrant and urban participants than rural participants (p<0.001), but varied by region. Sibling-pair analyses confirmed these results. There was no evidence of associations with time in urban area. Conclusions Rural to urban migration appears to be associated with both positive (higher fruit and vegetables intake) and negative (higher energy and fat intake) dietary changes. These changes may be of relevance to cardiovascular health and warrant public health interventions.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            The effect on cardiovascular risk factors of migration from rural to urban areas in Peru: PERU MIGRANT Study

            Background Mass-migration observed in Peru from the 1970s occurred because of the need to escape from politically motivated violence and work related reasons. The majority of the migrant population, mostly Andean peasants from the mountainous areas, tends to settle in clusters in certain parts of the capital and their rural environment could not be more different than the urban one. Because the key driver for migration was not the usual economic and work-related reasons, the selection effects whereby migrants differ from non-migrants are likely to be less prominent in Peru. Thus the Peruvian context offers a unique opportunity to test the effects of migration. Methods/Design The PERU MIGRANT (PEru's Rural to Urban MIGRANTs) study was designed to investigate the magnitude of differences between rural-to-urban migrant and non-migrant groups in specific CVD risk factors. For this, three groups were selected: Rural, people who have always have lived in a rural environment; Rural-urban, people who migrated from rural to urban areas; and, Urban, people who have always lived in a urban environment. Discussion Overall response rate at enrolment was 73.2% and overall response rate at completion of the study was 61.6%. A rejection form was obtained in 282/323 people who refused to take part in the study (87.3%). Refusals did not differ by sex in rural and migrant groups, but 70% of refusals in the urban group were males. In terms of age, most refusals were observed in the oldest age-group (>60 years old) in all study groups. The final total sample size achieved was 98.9% of the target sample size (989/1000). Of these, 52.8% (522/989) were females. Final size of the rural, migrant and urban study groups were 201, 589 and 199 urban people, respectively. Migrant's average age at first migration and years lived in an urban environment were 14.4 years (IQR 10–17) and 32 years (IQR 25–39), respectively. This paper describes the PERU MIGRANT study design together with a critical analysis of the potential for bias and confounding in migrant studies, and strategies for reducing these problems. A discussion of the potential advantages provided by the case of migration in Peru to the field of migration and health is also presented.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Addressing geographical variation in the progression of non-communicable diseases in Peru: the CRONICAS cohort study protocol

              Introduction In recent years, non-communicable diseases in low- and middle-income countries (LMIC) have received increasingly more global attention by scientists and by public health advocates and policy makers. Several publications underscore the high burden of disease associated with non-communicable diseases1–22 and its economic impact in LMIC.23–25 The topic has even reached to the higher political agenda at the United Nations in September 2011.26 Whole determinants of many non-communicable diseases in LMIC are likely to be similar to those in affluent countries, yet population attributable fractions may differ due to differences in risk factor distributions.27 There is urgent need to better characterise current rates of non-communicable disease morbidity and mortality in LMIC to properly assess future projections.28 Most of the current approaches to understand non-communicable disease trends in LMIC are extrapolations of data obtained from high-income countries; however, since 80% of deaths related to non-communicable diseases occur in LMIC,2 generation of local knowledge to address such problems is needed. This has been recommended by WHO in its recent ‘Prioritised Research Agenda for Prevention and Control of Non-Communicable Diseases’.29 Peru is a middle-income country where non-communicable diseases are responsible for 42% of total years of life lost30; however, mortality profiles are heterogeneous throughout the country and have rapidly shifted from a pattern dominated by infectious diseases to one dominated by non-communicable diseases and injuries over the last decade.31 As with other countries, cardiovascular disease (CVD) risk factors are strongly associated with lower socioeconomic status in Peru.32 33 Peru's diverse geography along with unequal societal development accounts for different stages of the epidemiological transition in different populations.34 35 In the same way, there is limited information about the burden of chronic obstructive pulmonary disease (COPD) in Peru. The PLATINO Study, which excluded Peru, found that the prevalence of COPD varied from 8% to 20% in individuals aged 40 years and older in five large Latin American cities, suggesting that COPD poses a considerable health burden in Latin America.36 Smoking was relatively prevalent (23%–29%) across the five cities included in PLATINO.37 In contrast, in Peru, we have recently found that overall rates of daily tobacco smoking are substantially lower than in other Latin American countries.38 However, other risk factors unique to LMIC such as biomass fuel exposure can contribute equally to the burden of COPD.39 40 Understanding the effects of rapid urbanisation is one of the grand challenges concerning chronic non-communicable diseases.41 Peru offers a unique opportunity to assess the impact of geographical variation on non-communicable diseases. Methods Study design and settings The CRONICAS cohort is a longitudinal study that started in September 2010. This study is currently being performed in three settings in Peru (table 1). Pampas de San Juan de Miraflores is a periurban community located 25 km south of Lima's city centre, with approximately 60 000 people in about 4 km2, consisting mostly of Andean immigrants. This area is physically diverse and has experienced significant but unplanned population growth, with residents living on both low and high ground. The site in Tumbes is located in the northern coast of Peru and comprised by a group of communities with about 20 000 people spread over 80 km2, where the traditional agricultural landscape has become intermixed with rapidly growing urban sections. Puno is a city in southeastern Peru, located on the shore of Lake Titicaca. With a population of approximately 150 000 inhabitants, many villages surround the urban area. Use of biomass fuels is highly prevalent in these villages. Houses are made of adobe, and the majority does not have chimneys, with small windows kept closed, especially in the winter, due to the low temperatures at high altitudes. Table 1 Characteristics of the CRONICAS Study settings Setting Degree of urbanisation Use of biomass fuels Outdoor air pollution Altitude Lima Highly urbanised Rare High Sea level Tumbes Semi-urban Highly prevalent Low Sea level Puno, urban Urban Rare Low 3825 m above sea level Puno, rural Rural Highly prevalent Low 3825 m above sea level Study objectives This study has the following objectives: to compare the (1) prevalence and risk factors of CVD and COPD, (2) rate of disease progression to hypertension and diabetes from a disease-free baseline status and (3) rate of lung function decline between populations. Participants and selection criteria All participants had to be aged 35 years and older, be a full-time resident in the area and be capable of understanding procedures and of providing informed consent. Participants who were pregnant, were cognitively incapable of providing informed consent or responding to a questionnaire, had any physical disability that would prevent measurements of anthropometrics and blood pressure and had active pulmonary tuberculosis were excluded. We enrolled only one participant per household. Fieldwork personnel selection and training Fieldwork personnel were trained in a course including modules on participant selection, human subjects protection and ethics, informed consent procedures, interviewing, clinical assessment and coding. The modules included formal lectures and demonstrations. Fieldworkers received a copy of an Interviewer's Manual. A team of approximately 30 field interviewers (10 per site) was selected. Additionally, a coordinator for each site was trained in this course. Thus, field personnel and coordinators were capable of conducting interviews and performing clinical assessments. Sampling method We identified a sex- and age-stratified random sample (35–44, 45–54, 55–64, ≥65 years of age) of potentially eligible subjects. We aimed to enrol 1000 subjects at each location. In Puno, we stratified recruitment to include 500 participants each from the urban and rural settings. Timeline: enrolment, baseline and follow-up visits Enrolment and baseline data collection started in September 2010. Follow-up visits will begin in February 2012 and an additional evaluation is planned to start in June 2013. At baseline, fieldworkers visited households to contact potential participants, verify inclusion and exclusion criteria, invite them to the study, read consent forms, apply questionnaires to participants and make an initial appointment for clinical evaluation. If potential participant was not found after three visits, a subject from the same age and sex group was randomly selected for replacement. The team had the responsibility to complete all clinical measurements and laboratory blood samples following standardised protocols. Recruitment of participants continued until the age- and sex-specific sample size was reached. Follow-up visits will be conducted at 20 and 40 months from enrolment. Sub-sections of the questionnaire as well as anthropometry, blood pressure and spirometry will be performed in all three visits. Blood sample collection will be undertaken only at baseline and at 40 months. Study procedures Questionnaires, informed consents, clinical forms and blood samples were labelled using alphanumeric codes to identify the site and participant. Questionnaires After informed consent was obtained, participants responded to a face-to-face questionnaire applied by a trained community health worker using paper-based formats. Data collected included several factors potentially associated with CVD and COPD, such as age, sex, years of education and other socioeconomic variables, smoking and alcohol habits, cardiovascular and respiratory symptoms, biomass fuel use and physical activity patterns. We used a modified version of WHO's STEP approach questionnaire for surveillance of non-communicable disease.42 Detailed information regarding sections and topics of the questionnaire is in table 2. In addition to the detailed survey, a rejection questionnaire comprising relevant questions to assure comparability between participants and non-responders was also applied to those who refuse to participate. Table 2 Sections and topics of the questionnaire in the CRONICAS Study Type of data Components Demographic assessment form: – Place and date – Language and informed consents – Contact information Socioeconomic assessment form: – Demographic information – Family and expenses – Household information – Biomass fuel use Lifestyle assessment form: – Short version of food frequency questionnaire – Salt consumption – Dietary behaviour questionnaire – Tobacco use and smoking – Alcohol use – Self-perception about health and obesity – Physical activity Neighbourhood walkability form: – Stores and facilities in the neighbourhood – Crime and traffic safety – Neighbourhood cohesion – Support Mental health form: – Depressive symptoms – Anxiety Migration assessment form: – Migration – Language use Treatment assessment form: – Cardiovascular medication – Pulmonary medication Cardiovascular form: – Personal and familial history – Stress chest pain – Intermittent claudication Respiratory symptoms form: – Respiratory symptoms – Sleep disorders – Snoring and apnoea Biomass exposure form: – Cooking – Type of cook stoves – Use of cook stoves – Biomass fuel use Clinical examination: – Anthropometric assessment form – Blood pressure assessment form – Ankle– brachial index form – Spirometry test form Phlebotomy and laboratory analyses A trained technician explained procedures for sample collection and then participants were asked to provide venous blood sample for specific tests (see table 3) in fasting conditions, at least 8 but 400 mg/dl, LDL was measured in serum. HDL, high-density lipoprotein; HS, high sensitive; LDL, low-density lipoprotein. Figure 1 Flow chart of biological samples processing at laboratory. Clinical assessment We measured standing and sitting height, waist and hip circumference in triplicate using standardised techniques, heart rate, systolic and diastolic blood pressure were in triplicate using an automatic monitor OMRON HEM-780, previously validated for adult population.43 Ankle–brachial index, a marker of subclinical atherosclerosis that predicts the risk of future vascular events,44 was also measured using the same device. We measured weight and bioelectrical impedance using the TBF-300A body composition analyzer (TANITA Corporation, Tokyo, Japan). Measurements were carried out according to manufacturer's specifications. Spirometry We measured lung function using the Easy-On-PC spirometer (ndd, Zurich, Switzerland; http://www.ndd.ch). This device uses a flow metre that is not affected by changes in barometric pressure and therefore independent of gas density and suitable for use at high altitudes. We trained technicians to comply with the joint European Respiratory Society and American Thoracic Society guidelines.45 After training, three of the most skilful technicians were selected to perform procedures. In addition, we had a centralised quality control system in which all tests were graded according to standard guidelines46 to ensure that data collected is of highest quality. Regular calibration checks were performed. We also provided feedback to fieldworkers regarding spirometry activities. We recorded forced vital capacity (FVC), forced expiratory volume in one second (FEV1) as well as store individual flow–volume curves for quality control assessment and further analysis. All patients underwent bronchodilator-response testing. We administered two puffs from a salbutamol inhaler (100 mcg/puff) via a spacer and repeated spirometry 10–15 min later (a generic salbutamol inhaler was used for this project). We did not perform spirometry to any subject who had surgery of heart, chest, lungs or eyes in the past 3 months, or heart attack in the past 3 months, and a blood pressure greater than 180 (systolic) or 100 (diastolic). We did not use bronchodilators in participants with a heart rate >120 beats for minute. We rescheduled spirometry at a later date for participants who reported having a respiratory infection in the last 2 weeks, who had used a short-term bronchodilators in the last 4 h or a long-term bronchodilators in the last 12 h or who had smoked in the last hour. Measures of indoor air pollution In the second round of assessments, we plan to measure particulate matter (PM) in a random sample of 10% of households (100 per site) by placing PM monitors in the kitchen area. Average PM concentrations will be measured with the DataRAM pDR-1000 (Thermo Fisher Scientific, Waltham, Massachusetts, USA). We expect to collect PM data over a 48 h period. We will also assess aspects of household ventilation by measuring size of room and any windows or doors, as well as noting their state (open or closed) and the location of the kitchen and proximity to the living space. We will also record whether there is a fan in the room and if it was used during the 48 h of data collection. Study outcomes The primary outcomes for the baseline assessment are prevalence of major risk factors for cardiopulmonary diseases. The primary outcomes for the follow-up include longitudinal changes in blood pressure, blood glucose and lung function over 40 months. We will also able to assess traditional risk factors for CVD and COPD in all follow-up visits. Hypertension rates will be calculated using the average of the second and third blood pressure measures. Hypertension will be defined as the systolic blood pressure ≥140 mm Hg, and/or diastolic blood pressure ≥90 mm Hg, and/or self-report of current use of antihypertensive drugs.47 Diabetes mellitus will be defined as a fasting glucose ≥126 mg/dl (or ≥7 mmol/l) or self-report of physician diagnosis and currently receiving antidiabetic medication.48 As local references do not exist, we will define COPD as the presence of airflow limitation characterised by FEV1/FVC 12% or >200 ml in baseline FEV1 or FVC in the post-salbutamol assessment.51 Sample size and power Calculations for CVD outcomes were derived using prevalence estimates of hypertension from PERU MIGRANT Study.38 52 Prevalence in urban (Lima), migrant and rural groups was 30%, 13% and 12%, respectively. With 1000 people in each study site, the study would have power ≥80%, at the 5% significance level, to detect a 3% absolute difference in the prevalence of progression to hypertension between the sites over 4 years (ie, 8% will develop hypertension in Lima, 5% in Puno and 2% in Tumbes). To calculate the sample size for determining a difference in prevalence of COPD between site, we assume a prevalence ranging from 6% in Lima to 12% in Tumbes or Puno, with 5% significance and 90% power. We estimate a sample size of approximately 509 participants per site. Sample size calculations for lung function assessment over time included parameter and variances estimates from the UPLIFT trial,53 a 4-year study of tiotropium in COPD, using the following model: FEV 1 ij heigh t i j 2 = β 0 + β 1 t ij + b 0 i + b 1 i t ij + ɛ ij , b i ∼ N ( ( 0 0 ) , ( σ 0 2 σ c σ c σ 1 2 ) ) and ɛ ij ∼ N ( 0 , σ 2 I ) . In this model, FEV1 is expressed in millilitres and height in metres. The outcome is equivalent to a height-adjusted FEV1. FEV1 is also affected by age, and this relationship is unlikely to be linear. However, we assume that the rate of decline over 40 months for each individual will be approximately linear. The values tij represents the jth measurement time for the ith participant. The βs are the regression parameters, and b i is the random effects. We used estimates obtained for male participants given that 75% of trial participants were male and that these estimates are likely to have the least amount of variability given the sample size of about 4000 participants. To calculate the sample size needed to detect a difference in our study from UPLIFT estimates, we used the following equation: n new = S E β 1 2 ( UPLIFT ) S E β 1 2 ( new ) ( L UPLIFT L new ) 2 n UPLIFT , where nnew is the sample size for our study; nUPLIFT is the sample size in UPLIFT trial; the SEs are the estimate of the SE for the expected β 1 in our study and in UPLIFT, respectively and L is the follow-up duration in our study and in UPLIFT. Since we expect to follow all individuals for approximately 4 years, our study duration is similar to that of UPLIFT. We obtained the sex-stratified estimates from UPLIFT investigators.53 The SE for our study can be estimated as: SE β 1 ( new ) = δ β 1 ⌢ Z ( 1 − power ) − Z (α) , where δ is the per cent difference between sites, β 1 ⌢ is the estimate of annual decline in FEV1 estimated from UPLIFT, Z(1-power) and Z(α) are the associated power and confidence level. Therefore, to detect a 50% change in the rate of decline in FEV1/height2 between sites with 5% significance and 90% power requires a total of 332 participants at each site followed longitudinally for 48 months. We assume that the rate of lung function decline for Tumbes will be similar to that of Lima. Assuming at 20% loss to follow-up, this would require approximately 400 participants. Even if we reduce the overall rate of decline in lung function by 25%, this would only increase the sample size requirement to 590 participants. Assuming at 20% loss to follow-up, this would require approximately 700 participants. Statistical methodology and analysis Following double data entry and careful data cleaning and consistency checking, descriptive statistics using tabulations and graphical methods will be performed. Direct standardisation to WHO standard population54 will be used to calculate age-standardised prevalences by specific age groups. Standardised mean differences, a unit-free comparison technique, will be used to evaluate the magnitude of difference between risk factors.55 56 The analysis will take into account the stratified nature of the sample at all stages and the repeated measures in individuals. Logistic regression (for binary outcomes) and multivariable linear regressions (for continuous normally distributed outcomes) will be used to assess the relationship between urbanisation and major cardiovascular and COPD risk factors. Appropriate longitudinal data methods will be used for the assessment of disease progression from baseline disease-free status to disease at follow-up. Multivariable models will look for risk factors that explain the relationship, such as blood pressure or fasting glucose when appropriate, body mass index, fasting total cholesterol, alcohol consumption, smoking status, regular exercise, income and other socioeconomic indicators as well as area of residence, will be pursued. Multilevel analysis to compare disease progression for site will be also considered. Ethical aspects This protocol and informed consent forms were approved with respect to scientific content and compliance with applicable research and human subjects' regulations. Protocol and consent forms were reviewed and approved by Institutional Review Boards at Universidad Peruana Cayetano Heredia and Johns Hopkins University. All investigators and personnel in the study have completed a training course in ethics and human subjects protection, certified by the National Institutes of Health. Informed consents were verbal because of sites included in this study were semi-urban and rural with significant rates of illiteracy; thus, interviewer signed the form to document participants' approval. Discussion This work emphasises the need of studies in different parts of the world, especially in LMIC to understand and assess non-communicable diseases and their risk factors. Peru is a very diverse country with different rates of urbanisation; thus, progression towards non-communicable conditions can vary widely from one geographical area to another. To our knowledge, two different cohorts are assessing non-communicable diseases in Latin America. The first one, the ELSA Study, a Brazilian cohort, has involved ‘white-collar’ volunteers to evaluate cardiovascular events.57 The second one, the CESCAS I Study, has started a cohort of participants focused in urban settings from Argentina, Chile and Uruguay to obtain CVD incidence using a multistage probabilistic sample.58 The burden of non-communicable in LMIC is only expected to increase, yet limited data are available in these settings. Extrapolation of trends using data from high-income countries, where age profiles, risk factors and body composition differ, is unlikely to provide reasonable estimates or public health strategies to decrease disease burden. Generation of local knowledge to address such problems is needed to measure the magnitude of the problem, assess risk factors, which might be completely different from developed countries, and identify high-risk groups.59 The CRONICAS cohort has established a large cardiopulmonary cohort of adults, who will be followed-up over at least 4 years, with the possibility of longer term follow-ups and thus establishing itself as a unique resource arising from one LMIC in an area of major public health concern. There are several strengths that distinguish our study from other large-scale studies in Latin America. On the cardiovascular side, the assessment of risk using scores derived from developed countries has shown limitations in developing societies and may have limited application in settings like Peru. Determination of non-communicable disease epidemiology requires context-specific evaluation and follow-up of subjects over time, and this information is not available for Peru. On the pulmonary side, our study findings will complement that of BOLD and PLATINO as we will be able to provide an evaluation of longitudinal assessments of lung function across several settings according to degree of urbanisation, levels of outdoor and indoor air pollution and altitude. Specifically, our research will expand on the knowledge base of the epidemiology of lung function in LMIC with a high prevalence of biomass fuel exposure. Moreover, our data can also be used to generate local references for lung function among healthy, non-smoking non-biomass fuel-exposed adults, which currently do not exist for Peru. Most importantly, the uniqueness of geographical settings, the variety of stages of urbanisation, the long-term design of the study in an LMIC and the integration of cardiovascular- and pulmonary-related assessments will generate comprehensive data that will, in turn, provide important advances for public health and for the field of non-communicable diseases in LMIC. In Peru, according to WHO's 2011 non-communicable diseases country profile, there is no data regarding behavioural risk factors, especially in current daily tobacco smoking and physical inactivity prevalences.60 In addition, this report highlights the lack of an integrated policy programme for CVD, chronic respiratory diseases, diabetes, cancer, alcohol, tobacco, unhealthy diet, obesity and physical inactivity.60 Therefore, reducing the impact of non-communicable diseases will require alliances between different groups of research beyond national boundaries. With the support of the National Heart, Lung, and Blood Institute, we have the opportunity to establish initial steps towards an appropriate surveillance system for chronic diseases in Peru. The information gathered in this protocol will provide a strong platform to address potential interventions that are locally relevant and that could be applicable to other settings in Latin America, other LMIC and eventually potentially relevant for Latin population in the USA.
                Bookmark

                Author and article information

                Journal
                Int J Epidemiol
                Int J Epidemiol
                ije
                International Journal of Epidemiology
                Oxford University Press
                0300-5771
                1464-3685
                December 2017
                25 July 2017
                25 July 2017
                : 46
                : 6
                : 1752-1752f
                Affiliations
                [dyx116-1 ]CRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru,
                [dyx116-2 ]Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK,
                [dyx116-3 ]Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA and
                [dyx116-4 ]Department of Medicine, School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru
                Author notes
                Corresponding author. CRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Av. Armendáriz 497, 2do Piso, Miraflores, Lima 18, Peru. E-mail: jaime.miranda@ 123456upch.pe
                Article
                dyx116
                10.1093/ije/dyx116
                5837622
                29040556
                7de5ab2d-c4e9-45cb-b2a9-484a2c5c7ebf
                © The Author 2017. Published by Oxford University Press on behalf of the International Epidemiological Association

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 1 June 2017
                : 9 June 2017
                Page count
                Pages: 7
                Funding
                Funded by: National Institutes of Health 10.13039/100000002
                Funded by: National Heart, Lung, and Blood Institute 10.13039/100000050
                Funded by: Wellcome Trust 10.13039/100004440
                Categories
                Cohort Profiles

                Public health
                Public health

                Comments

                Comment on this article